Payment overview · 2025
General Payments
$37.46
2 reported records · 2 companies
Healthcare provider profile · identity verified
Hugh Morgan Ashurst, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MOBILE, AL · NPI 1952309965
Verified facts
What the public records show
CMS Open Payments records show Hugh Morgan Ashurst, MD received $37.46 in general payments during 2025 across 2 reported records.
Neurocrine BioSciences, Inc. accounted for 51.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $19.11 | 51.0% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $18.35 | 49.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $37.46 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $19.11 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $18.35 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 760 | 252 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 515 | 145 |
| Pantoprazole Sodium | Pantoprazole Sodium | 473 | 162 |
| Losartan Potassium | Losartan Potassium | 444 | 144 |
| Atorvastatin Calcium | Atorvastatin Calcium | 442 | 146 |
| Ezetimibe | Ezetimibe | 397 | 123 |
| Levothyroxine Sodium | Levothyroxine Sodium | 395 | 117 |
| Trazodone Hcl | Trazodone Hcl | 377 | 113 |
| Furosemide | Furosemide | 358 | 124 |
| Escitalopram Oxalate | Escitalopram Oxalate | 314 | 91 |
| Potassium Chloride | Potassium Chloride | 313 | 102 |
| Gabapentin | Gabapentin | 283 | 88 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 276 | 91 |
| Spironolactone | Spironolactone | 276 | 89 |
| Metoprolol Succinate | Metoprolol Succinate | 272 | 85 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 263 | 106 |
| Ozempic | Semaglutide | 240 | 50 |
| Duloxetine Hcl | Duloxetine Hcl | 233 | 66 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 218 | 51 |
| Tramadol Hcl | Tramadol Hcl | 215 | 55 |
| Buspirone Hcl | Buspirone Hcl | 206 | 59 |
| Omeprazole | Omeprazole | 200 | 69 |
| Carvedilol | Carvedilol | 172 | 48 |
| Hydralazine Hcl | Hydralazine Hcl | 161 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 157 | 59 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 157 | 49 |
| Metformin Hcl | Metformin Hcl | 148 | 52 |
| Clonazepam | Clonazepam | 138 | 23 |
| Sertraline Hcl | Sertraline Hcl | 135 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 122 | 41 |
| Aripiprazole | Aripiprazole | 116 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 115 | 33 |
| Donepezil Hcl | Donepezil Hcl | 114 | 23 |
| Mounjaro | Tirzepatide | 113 | 23 |
| Allopurinol | Allopurinol | 111 | 39 |
| Glimepiride | Glimepiride | 110 | 39 |
| Eliquis | Apixaban | 103 | 22 |
| Metformin Hcl Er | Metformin Hcl | 102 | 30 |
| Alprazolam | Alprazolam | 101 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 101 | 37 |
| Quetiapine Fumarate | Quetiapine Fumarate | 94 | 24 |
| Zolpidem Tartrate | Zolpidem Tartrate | 92 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 88 | 23 |
| Bupropion Xl | Bupropion Hcl | 87 | 28 |
| Clonidine Hcl | Clonidine Hcl | 80 | 28 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 78 | 23 |
| Mirtazapine | Mirtazapine | 78 | 23 |
| Meloxicam | Meloxicam | 77 | 21 |
| Tamsulosin Hcl | Tamsulosin Hcl | 77 | 28 |
| Simvastatin | Simvastatin | 75 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 74 | 43 |
| Nortriptyline Hcl | Nortriptyline Hcl | 72 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 70 | 32 |
| Lisinopril | Lisinopril | 70 | 25 |
| Midodrine Hcl | Midodrine Hcl | 69 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 67 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 64 | 18 |
| Diltiazem Hcl | Diltiazem Hcl | 60 | 12 |
| Sucralfate | Sucralfate | 58 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 20 |
| Jardiance | Empagliflozin | 56 | 16 |
| Meclizine Hcl | Meclizine Hcl | 55 | 22 |
| Famotidine | Famotidine | 49 | 19 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 48 | 16 |
| Prednisone | Prednisone | 47 | 33 |
| Pregabalin | Pregabalin | 46 | 12 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 46 | 17 |
| Xultophy 100-3.6 | Insulin Degludec/Liraglutide | 44 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 40 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 39 | 13 |
| Azelastine Hcl | Azelastine Hcl | 38 | 27 |
| Farxiga | Dapagliflozin Propanediol | 37 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 36 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 16 |
| Azithromycin | Azithromycin | 34 | 33 |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 34 | 12 |
| Montelukast Sodium | Montelukast Sodium | 34 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 32 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 32 | 11 |
| Rybelsus | Semaglutide | 32 | 17 |
| Cefdinir | Cefdinir | 31 | 29 |
| Cephalexin | Cephalexin | 30 | 26 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 30 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 28 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | 13 |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 27 | 11 |
| Temazepam | Temazepam | 27 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 25 | suppressed |
| Nystatin | Nystatin | 25 | 14 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Colchicine | Colchicine | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 23 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 23 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 20 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Lorazepam | Lorazepam | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 17 | suppressed |
| Metoprolol-Hydrochlorothiazide | Metoprolol/Hydrochlorothiazide | 17 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 15 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 13 |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 13 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Repatha Syringe | Evolocumab | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Finasteride | Finasteride | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $37.46 · 2 records | Neurocrine BioSciences, Inc. | Cologuard Collection Kit, INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error